{"SPADE_UN_00309": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2008/0207522 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2008_0207522_A1", "Patent Type": "Patent Application", "Publication Date": "2008-8-28", "Family Info": "CA2629751A1,EP1824976A1,EP1824976A4,EP2116603A2,EP2116603A3,WO2006050611A1", "Patent Title": "Antimicrobial Peptides.", "Abstract": "A novel class of peptides having antimicrobial activity is provided. Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Pharmaceutical compositions comprising the novel class of peptides are also provided."}], "Sequence Information": {"SPADE ID": "SPADE_UN_00309", "Peptide Name": "Sub3 (Bac2A variant through three amino acids substitution)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "RRWRIVVIRVRR", "Sequence Length": 12, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Antifungal"], "Target Organism": "Gram-negative bacteria:Pseudomonas aeruginosa (MIC=2 µg/ml), Escherichia coli (MIC=2.5 µg/ml), Salmonella typhimurium (MIC=4 µg/ml);Gram-positive bacteria:Staphylococcus aureus (MIC=2 µg/ml), Staphylococcus epidermidis (MIC=0.2 µg/ml), Enterococcus faecalis (MIC=4 µg/ml).Yeast:Candida albicans (MIC=4 µg/ml).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C74H133N31O13", "Mass": 1665.05, "PI": 12.0, "Net Charge": 6, "Hydrophobicity": -0.53, "Half Life": "With a half-life of approximately 1h in 25% aqueous mouse serum,Sub3 was relatively stable for a medium-sized peptide.", "Function": "Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.", "Chemical modification": "C-terminal amidation.", "Literature": [{"Title": "High-throughput generation of small antibacterial peptides with improved activity.", "Pubmed ID": "16041366", "Reference": "Nat Biotechnol. 2005 Aug;23(8)1008-1012.", "Author": "Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16041366"}, {"Title": "The PhoQ-activating potential of antimicrobial peptides contributes to antimicrobial efficacy and is predictive of the induction of bacterial resistance", "Pubmed ID": "", "Author": "Kindrachuk J, Paur n, Reiman C, Scruten E, napper S"}, {"Title": "High-throughput generation of small antibacterial peptides with improved activity", "Pubmed ID": "", "Author": "Hilpert K, Volkmer-Engert R, Walter T, Hancock RE"}, {"Title": "Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis", "Pubmed ID": "", "Author": "Rivas-Santiago B, Rivas Santiago CE, Castaneda-Delgado JE, Leon-Contreras JC, Hancock RE, Hernandez-"}, {"Title": "The antimicrobial activity of Sub3 is dependent on membrane binding and cell-penetrating ability", "Pubmed ID": "", "Author": "Torcato IM, Huang YH, Franquelim HG, Gaspar DD, Craik DJ, Castanho MA, Henriques ST"}], "Frequent Amino Acids": "RVI", "Absent Amino Acids": "ACDEFGHKLMNOPQSTUY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 9, "Positive Residues": 6, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_04903", "Similarity": 1.0, "Sequence": "RQARRNRRRRWR"}, {"SPADE_ID": "SPADE_N_08934", "Similarity": 1.0, "Sequence": "WGRRRWGPGRRYRRW"}, {"SPADE_ID": "SPADE_N_08942", "Similarity": 1.0, "Sequence": "WGRRGWGPGRRYRRWR"}]}}}